NSEInvestor Presentation6d ago · 15 Jul 2026, 09:13 pm

Investor Presentation

Dhampur Bio Organics Limited · DBOL

✦ AI SummaryResults

Dhampur Bio Organics Limited has informed the Exchange about Investor Presentation for Q1 FY 2026-27.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dhampur Bio Organics Limited has informed the Exchange about Investor Presentation

Attachments (1)

📄

DBOLTD_15072026211306_InvPrez_DBOtoSE.pdf

pdf

Download →
View document text
Dhampur Bio Organics Ltd. Date: July 15, 2026 The Manager – Listing The Manager – Listing Dept of Corp. Services, National Stock Exchange of India Ltd. BSE Limited Exchange plaza, Bandra Kurla Complex P.J. Towers, Dalal Street, Fort, Bandra East Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 543593 Symbol: DBOL Dear Sir/Ma’am, Sub: Investor Presentation: Q1 FY 2026 – 27 Please find attached herewith Investor Presentation on the performance of the Company for the quarter ended June 30, 2026. The same is also being uploaded on the website of the Company i.e. www.dhampur.com. You are requested to take the same on record. Thanking you Your Sincerely, For Dhampur Bio Organics Limited Ashu Rawat Company Secretary & Compliance officer Corp. Office: Second Floor, Plot No. 201, Okhla Industrial Estate, Phase III, New Delhi – 110 020, India, Tel: +91-11 – 6905 5200, Email: corporateoffice@dhampur.com, Website: www.dhampur.com Regd. Office: Sugar Mill Compound, Village & Post – Asmoli, Distt. Sambhal, Uttar Pradesh – 244304, Tel: +91-7302318313 CIN : L15100UP2020PLC136939 Dhampur Bio Organics Limited A leading integrated sugarcane processing company in India Q1FY27 Results Presentation Safe Harbour Statement This presentation is strictly confidential and may not be copied, published, distributed or transmitted. The information in this presentation is being provided by Dhampur Bio Organics Limited (also referred to as the ‘Company’). By attending the meeting where this presentation is being made or by reading the presentation materials, you agree to be bound by following limitations: The information in this presentation has been prepared for use in presentations by the Company for information purposes only and does not constitute, or should be regarded as, or form part of any offer, invitation, inducement or advertisement to sell or issue, or any solicitation or initiation of any offer to purchase or subscribe for, any securities of the Company in any jurisdiction, including the United States and India, nor shall it, or the fact of its distribution form the basis of, or be relied on in connection with, any investment decision or any contract or commitment to purchase or subscribe for any securities of the Company in any jurisdiction, including the United States and India. This presentation does not constitute a recommendation by the Company or any other party to sell or buy any securities of the Company. This presentation and its contents are not and should not be construed as a prospectus or an offer document, including as defined under the Companies Act, 2013, to the extent notified and in force) or an offer document under the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 as amended. This presentation and its contents are strictly confidential to the recipient and should not be further distributed, re-transmitted, published or reproduced, in whole or in part, or disclosed by recipients directly or indirectly to any other person or press, for any purposes. In particular, this presentation is not for publication or distribution or release in any country where such distribution may lead to a breach of any law or regulatory requirement. No person is authorized to give any information or to make any representation not contained in or inconsistent with this presentation or and if given or made, such information or representation must not be relied upon as having been authorized by us. Receipt of this presentation constitutes an express agreement to be bound by such confidentiality and the other terms set out herein. Any failure to comply with this restriction may constitute a violation of applicable securities laws. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Neither the Company nor any of its affiliates, advisors or representatives shall have any responsibility or liability whatsoever (for negligence or otherwise) for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection with this presentation. The information set out herein may be subject to updating, completion, revision, verification and amendment and such information may change materially. This presentation is based on the economic, regulatory, market and other conditions as in effect on the date hereof. It should be understood that subsequent developments may affect the information contained in this presentation, which neither the Company nor its affiliates, advisors or representatives are under an obligation to update, revise or affirm. This presentation contains forward-looking statements based on the currently held beliefs and assumptions of the management of the Company, which are expressed in good faith and, in their opinion, reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance, or achievements of the Company or industry results, to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements. Unless otherwise indicated, the information contained herein is preliminary and indicative and is based on management information, current plans and estimates. Industry and market-related information is obtained or derived from industry publications and other sources and has not been independently verified by us. Given these risks, uncertainties and other factors, recipients of this document are cautioned not to place undue reliance on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements to reflect future events or developments. THIS PRESENTATION IS NOT AN OFFER FOR SALE OF SECURITIES IN INDIA OR ELSEWHERE. CCoommppaannyy OOvveerrvviieeww Company at a Glance Business Overview Dhampur Bio Organics Limited (DBO) is a leading cane processing company with experience and pedigree extending across 9 decades. Utilising its advanced and integrated manufacturing setups, DBO capitalises on the favourable trends in the sugar and broader agricultural economy. The company is focussed on repositioning itself as a value-added sugar and spirits manufacturer on one hand and a bio-energy company on the other. The two manufacturing facilities – in Asmoli and Mansurpur; are strategically located in proximity to each other enabling better utilisation of resources and increased synergies in production and management. ₹ 2,082 Crores FY26 Revenue (Net of DBO operates in three business verticals Excise) ₹ 162 Crores FY26 EBITDA 0.28x Long-term Debt to Equity Sugar Biofuels & Spirits Country Liquor as on 31st March 26 DBO has a rich legacy and DBO, through its distillery in To meet its levy obligations, extensive experience in the Asmoli, produces Ethanol, DBO has extended a part of its sugar sector, Refined Sugar utilizing Syrup, B-Heavy & C- distillery capacity in Asmoli to (available in packed and Heavy Molasses as key the production of Country branded variants), White Sugar, feedstocks. DBO is also Liquor or “Indian Made Indian Retail Sugar and Pharma-grade focussing on producing ethanol Liquor (IMIL)”. The company’s Sugar (approved by Food Safety through dual feed plant – products are available in Tetra and Standards Authority of sugarcane and grain packs and packed bottles. India). Company at a Glance Mansurpur Asmoli Plant Plant Total Uttar Capacity Company Completed the sale (District (District Capacity Pradesh of Meerganj Unit on 18th Sambhal) Muzaffanagar) Sugar June 2026 Sugarcane Crushing (TCD) 12,500 8,000 20,500 2 Integrated manufacturing facilities Sugar Refinery (TPD) 1,100 900 2,000 Pharma Grade Sugar (TPD) 700 _ 700 20,500 TCD Consolidated Sugarcane LQW Sugar (TPD) _ _ 0 Crush [Showing first 8,000 characters — download PDF for full document]